Full-Time

Vice President

Intellectual Property

Confirmed live in the last 24 hours

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops small molecule protein degraders

Biotechnology

Senior

Belmont, MA, USA

Required Skills
Communications
Requirements
  • JD with admission to the bar
  • Admitted to practice before the U.S. Patent and Trademark Office
  • 12+ years of intellectual property experience
  • PhD in Chemistry preferred
  • Experience with small molecules
  • Strong organizational skills
  • Exceptional written and oral communication skills
Responsibilities
  • Lead legal activities for platform technologies and targets
  • Oversee preparation and prosecution of global portfolio
  • Advise on emerging legal issues in intellectual property
  • Negotiate IP terms of licensing agreements
  • Lead preparation and prosecution of patent applications
  • Monitor competitor portfolios

Kymera Therapeutics, specializing in developing small molecule protein degraders for immunology-inflammation and oncology, utilizes their cutting-edge Pegasus platform to target and degrade disease-causing proteins effectively. This focus not only places them at the forefront of biomedical research within these critical health areas but also fosters a culture of technical excellence and leadership in medical innovation. An employment opportunity at this company promises a collegiate environment where scientific rigor is paired with a commitment to improving patient outcomes through pioneering therapies.

Company Stage

IPO

Total Funding

$879M

Headquarters

Watertown, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

10%

2 year growth

33%